Fund

Boyu Capital

博裕资本

elsewhere's corpus doesn't profile Boyu Capital directly — no founding story, team, or fund-size coverage — so what's available is a picture assembled from its deal activity. It shows up as a large Chinese investment house straddling PE and growth/VC: it led logistics firm Yimi Dida's RMB 1.8 billion Series D in January 2019 [^C6 placeholder], and held a 6.1% stake in J&T Express — worth roughly US$800 million at the market cap cited in a 2023 暗涌Waves piece . More recent activity skews to frontier tech under its "Boyu Growth Ventures" arm: it joined biotech rounds for EonArk (无尽方舟) in 2026 , added to NeoImmuneTech's $38 million raise , and sat on the cap table of stellarator fusion startup Azure Star alongside Gaorong and Oasis . It also surfaced in the news in November 2024 as one of five Recurrent AI investors who filed arbitration against Kimi founder Yang Zhilin, per 暗涌Waves .

AI-generated — may contain errors, please verify.

Boyu CapitalFund
博裕资本
渲染中…
Mentioned in 23 articles

Coverage